Rethinking Medicinal Cannabis
Hugh Hempel, a technology industry veteran, has become a health care entrepreneur and a surprising supporter of medicinal cannabis. In 2006, his identical twin daughters were diagnosed with Niemann Pick Type C, a rare and fatal neurodegenerative disease, often referred to as “Childhood Alzheimer’s.” Since then, Hugh and his wife have done a lot of research and discovered that a simple sugar compound called cyclodextrin could save their daughters lives. They have successfully filed applications with U.S. Food and Drug Administration (FDA) and received permission to try this never before used treatment on their daughters. Their journey to develop...
Read More